PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study for Oral Presentation at 2021 ASCO MeetingGlobeNewsWire • 05/20/21
PDS Biotechnology Appoints Immuno-Oncology Experts Dr. Olivera Finn and Dr. Mark Frohlich to Scientific Advisory BoardGlobeNewsWire • 05/18/21
NetScientific portfolio firm PDS Biotech sells off New Jersey tax benefitsProactive Investors • 05/18/21
PDS Biotechnology Corp (PDSB) CEO Frank Bedu-Addo on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/13/21
PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial ResultsGlobeNewsWire • 05/13/21
PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at 2021 American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 04/29/21
PDS Biotechnology Announces Conference Call and Webcast for First Quarter Financial ResultsGlobeNewsWire • 04/26/21
PDS Biotech Announces Participation in Noble Capital Markets Virtual Road Show SeriesGlobeNewsWire • 04/19/21
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 03/18/21
PDS Biotech Reports Financial Results for the Year Ended December 31, 2020 and Provides Business UpdateGlobeNewsWire • 03/18/21
PDS Biotech Announces that its COVID-19 Vaccine Consortium Received a Commitment from The Ministry of Science, Technology and Innovation of Brazil (MCTI) to fund Clinical Development and Commercialization of a Versamune®-Based COVID-19 Vaccine with an AwaGlobeNewsWire • 03/11/21
PDS Biotechnology Announces Conference Call and Webcast for Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 03/08/21
PDS Biotech Announces Presentations in Upcoming Healthcare Investor ConferencesGlobeNewsWire • 03/03/21
PDS Biotech and Farmacore Announce Blanver to Join Consortium to Commercialize Novel Versamune®-Based T-Cell Inducing COVID-19 VaccineGlobeNewsWire • 02/22/21
PDS Biotechnology Moves Forward With Full Enrollment In PDS0101 Trial In HPV-Associated Cancers, Shares RetreatBenzinga • 02/03/21
PDS Biotech Releases White Paper Detailing the Potential of the Versamune® Platform in Overcoming a Major Limitation of Immuno-OncologyGlobeNewsWire • 01/14/21
PDS Biotech Announces Participation in H.C. Wainwright BioConnect 2021 Virtual ConferenceGlobeNewsWire • 01/05/21
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/12/20
PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 VaccineGlobeNewsWire • 11/10/20